Resum
AIM: To elicit patients' preferences for HIV/AIDS treatment characteristics in Colombia. MATERIALS AND METHODS: A best-worst scaling case was used to provide a ranking of 26 HIV/AIDS treatment characteristics that were similar to a previous study conducted in Germany. In each choice task, system intent of achieving the highest degree of
health and wellbeing, it secures the basic material
conditions required for capabilities to flourish
becoming the best alternative for greater participation
in the construction of individual life projects;
it would consider the reality of the people in their
sociocultural environments and would allow to pull
the female world out of the private realm to allow
a public debate on these matters and prevent them
from being considered as “natural” unchangeable
aspects of human relations. This would ensure
greater relevance in terms of meeting the needs of
each population. The article also highlights that the
social justice that characterises this approach will
not come from the top, from the State, but requires
collective participation, where movements that oppose
hegemony play a very important role and are
active in building their own capabilities.participants were asked to choose the most important and the least important treatment characteristics from a set of five from the master list. Using the Hierarchical Bayes method, relative importance scores were calculated. Sub-group analyses were conducted according to sex, education, source of infection, symptoms, and age. RESULTS: A total of 195 patients fully completed the questionnaire. The three most important characteristics were "drug has very high efficacy" (relative importance score [RIS] = 10.1), "maximum prolongation of life expectancy" (RIS = 9.7), and "long duration of efficacy" (RIS = 7.4). Sub-group analysis showed only three significant (but minor) differences between older and younger people. CONCLUSION: This study suggests that treatment characteristics regarding efficacy and prolongation of life are particularly important for patients in Colombia. Further investigation on how patients make trade-offs between these important characteristics and incorporating this information in clinical and policy decision-making would be needed to improve adherence with HIV/AIDS medication.